Apatinib for treatment of a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report

BACKGROUND: Pseudomyxoma peritonei (PMP) is a rare benign, but progressive, disease according to myxoma histopathology. Surgical resection is the preferred and most effective treatment, but the outcomes are often unsatisfactory. CASE SUMMARY: A 63-year-old Chinese woman with PMP received apatinib at...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rong, Shi, Xiu-Ling, Wang, Yun-Fei, Yang, Fei, Wang, Ting-Tao, Peng, Cun-Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887607/
https://www.ncbi.nlm.nih.gov/pubmed/31799318
http://dx.doi.org/10.12998/wjcc.v7.i22.3881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887607/
https://www.ncbi.nlm.nih.gov/pubmed/31799318
http://dx.doi.org/10.12998/wjcc.v7.i22.3881

Ejemplares similares